Nasal polyps are soft, painless growths on the lining of your nasal passages or sinuses, often resulting from chronic inflammation. While these benign growths themselves are not harmful ...

Nasal polyps are small, noncancerous growths that ... in the nasal passages and make these symptoms worse. Avoiding these types of triggers can help reduce symptoms. Nasal rinses — with a ...

Amgen (AMGN) and AstraZeneca's (AZN) asthma therapy Tezspire hits main goals in the Phase 3 trial for chronic rhinosinusitis ...

A deviated septum occurs when you have two different-sized nasal passageways which can cause one-sided congestion.

Topline results from a phase 3 trial show that tezepelumab statistically significantly reduced the size of nasal polyps and nasal congestion in adults with chronic rhinosinusitis with nasal polyps ...

Depemokimab targets interleukin-5, a key cytokine linked to type 2 inflammation, which is prevalent in nasal polyp tissue.

Depemokimab is an inhibitor of IL-5, which is a key cytokine (protein) in type II inflammation. IL-5 is present at high levels in nasal polyp tissue. IL-5 inhibitors play a key role in reducing ...

Both studies hit their co-primary endpoints of demonstrating that depemokimab improved the total endoscopic nasal polyp score at 52 ... will exhibit markers of type 2 inflammation,” Kaivan ...

the majority of whom will exhibit markers of type 2 inflammation. These patients have high corticosteroid exposure and often experience recurrence of nasal polyps following surgery. We’re very ...